Genome Designs Partners with SciDM Group
News Apr 26, 2012
Genome Designs, Inc. has announced a partnership with SciDM Group, a bioinformatics tools developer.
Genome Designs will be using SciDM Group’s high performance database engine, transcriptomics data processing pipeline, and high throughput sequence comparison technology.
The tools will be used to augment Genome Designs’ existing genome annotation pipelines and to boost custom software development projects for clients.
“SciDM Group strives to provide computational biologists with fast and flexible data management and bioinformatics tools, capable of keeping the pace with the progress of high-throughput data acquisition technologies, for example, with the recent avalanche of sequencing data,” said Denis Kaznadzey, the leader of SciDM Group.
Kaznadzey continued, “Our tools are free, most are open source and available for download from public repositories. However, they require integration with the client’s system. Our partnership with Genome Designs goes beyond just another vendor-client relationship: they are planning to provide installation and integration services for our products”.
SciDM Group’s flagship product, a database management system, is a zero-maintenance object-relational database engine optimized for dealing with extremely large volumes of data.
On typical bioinformatics tasks like sequence assembly and clustering, SciDM Data Manager operates thousands of times faster than conventional database engines, including popular commercial brands.
Other tools by SciDM Group similarly allow considerable performance optimization and subsequent gain in speed: QSimScan (Quick SIMilarity SCANner) performs 5 to 100 times faster than standard NCBI BLAST depending on search parameters, and EST pipeline efficiently converts raw transcriptomics data into normalized gene expression profiles.
“Since our beginning of operation, we have seen a considerable interest in our custom genome annotation and metabolic engineering services. However, our potential clients often needed more than that: we experienced a strong demand for custom software tools,” commented Natalia Alexandrova, CEO of Genome Designs.
Alexandrova continued, “Originally, such projects have been beyond our scope, but our partnership with SciDM Group will allow us to shorten development cycles and deliver robust systems without changing the focus of the company, and to higher customer’s satisfaction”.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
New Algorithms Help Extract 3-D Biological Structure from Limited DataNews
CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018